Skip to main content
. 2022 Apr 29;14:877078. doi: 10.3389/fnagi.2022.877078

FIGURE 5.

FIGURE 5

Variations in the trends of the metabolites that are biomarkers of both PD and Cy-3-G treatment. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Control; #p < 0.05, ##p < 0.01 vs. Model.